<table border="1" id="id_f53f5f42-ffaf-4e6c-8886-3f9624582e7d" width="0.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 1. Ranitidine Pharmacokinetics in Pediatric Patients Following Oral Dosing</caption>
<col span="1"></col>
<col span="1"></col>
<col span="1"></col>
<col span="1"></col>
<col span="1"></col>
<tbody>
<tr>
<td>Population (age)</td>
<td>n</td>
<td>Dosage Form (dose)</td>
<td>C<sub>max</sub> (ng/mL)</td>
<td>T<sub>max</sub> (hours)</td>
</tr>
<tr>
<td>Gastric or duodenal ulcer (3.5 to 16 years)</td>
<td>12</td>
<td>Tablets (1 to 2 mg/kg)</td>
<td>54 to 492</td>
<td>2.0</td>
</tr>
</tbody>
</table>